[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Page 64020]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-25076]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration; 
Sigma Aldrich Research Biochemicals, Inc.

    By Notice dated May 24, 2013, and published in the Federal Register 
on June 4, 2013, 78 FR 33442, Sigma Aldrich Research Biochemicals, 
Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760-2447, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the following basic classes of 
controlled substances:

 
------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Mephedrone (4-Methyl-N-methylcathinone)      I
 (1248).
MDPV (3,4-Methylenedioxypyrovalerone)        I
 (7535).
Methylone (3,4-Methylenedioxy-N-             I
 methylcathinone) (7540).
Sufentanil (9740)..........................  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a), and determined that the registration 
of Sigma Aldrich Research Biochemicals, Inc., to manufacture the listed 
basic classes of controlled substances is consistent with the public 
interest at this time. DEA has investigated Sigma Aldrich Research 
Biochemicals, Inc., to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems; 
verification of the company's compliance with state and local laws; and 
a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed.

    Dated: October 16, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-25076 Filed 10-24-13; 8:45 am]
BILLING CODE 4410-09-P